Cangrelor in cardiogenic shock and after cardiopulmonary resuscitation: A global, multicenter, matched pair analysis with oral P2Y12 inhibition from the IABP-SHOCK II trial.
Sign Up to like & getrecommendations! Published in 2019 at "Resuscitation"
DOI: 10.1016/j.resuscitation.2019.02.008
Abstract: AIMS Cangrelor has a potentially favorable pharmacodynamic profile in cardiogenic shock (CS). We aimed to evaluate the clinical course of CS patients undergoing percutaneous coronary intervention (PCI) treated with cangrelor. METHODS AND RESULTS We retrospectively… read more here.
Keywords: oral p2y12; iabp shock; cangrelor; cardiogenic shock ... See more keywords